Literature DB >> 31050910

Reply to C.J. Sweeney et al.

Ravi B Parikh1, Vinay Prasad1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31050910      PMCID： PMC6879314          DOI： 10.1200/JCO.19.00451

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  10 in total

1.  What Does Metastasis-Free Survival Actually Mean?

Authors:  Christopher J Sweeney; Richard De Abreu Lourenco; Anis A Hamid; Marc Buyse
Journal:  J Clin Oncol       Date:  2019-05-03       Impact factor: 44.544

2.  Metastasis-Free Survival in Prostate Cancer: Faster Drug Approvals, Better Drugs?

Authors:  Ravi B Parikh; Vinay Prasad
Journal:  J Clin Oncol       Date:  2018-12-11       Impact factor: 44.544

3.  Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

Authors:  Matthew R Smith; Fred Saad; Simon Chowdhury; Stéphane Oudard; Boris A Hadaschik; Julie N Graff; David Olmos; Paul N Mainwaring; Ji Youl Lee; Hiroji Uemura; Angela Lopez-Gitlitz; Géralyn C Trudel; Byron M Espina; Youyi Shu; Youn C Park; Wayne R Rackoff; Margaret K Yu; Eric J Small
Journal:  N Engl J Med       Date:  2018-02-08       Impact factor: 91.245

4.  Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.

Authors:  Maha Hussain; Karim Fizazi; Fred Saad; Per Rathenborg; Neal Shore; Ubirajara Ferreira; Petro Ivashchenko; Eren Demirhan; Katharina Modelska; Andrew Krivoshik; Cora N Sternberg
Journal:  N Engl J Med       Date:  2018-06-28       Impact factor: 91.245

Review 5.  A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics: A Review.

Authors:  Julia A Beaver; Lynn J Howie; Lorraine Pelosof; Tamy Kim; Jinzhong Liu; Kirsten B Goldberg; Rajeshwari Sridhara; Gideon M Blumenthal; Ann T Farrell; Patricia Keegan; Richard Pazdur; Paul G Kluetz
Journal:  JAMA Oncol       Date:  2018-06-01       Impact factor: 31.777

Review 6.  The high price of anticancer drugs: origins, implications, barriers, solutions.

Authors:  Vinay Prasad; Kevin De Jesús; Sham Mailankody
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

7.  High cancer drug prices in the United States: reasons and proposed solutions.

Authors:  Hagop Kantarjian; David Steensma; Judit Rius Sanjuan; Adam Elshaug; Donald Light
Journal:  J Oncol Pract       Date:  2014-05-06       Impact factor: 3.840

8.  American Society of Clinical Oncology guidance statement: the cost of cancer care.

Authors:  Neal J Meropol; Deborah Schrag; Thomas J Smith; Therese M Mulvey; Robert M Langdon; Diane Blum; Peter A Ubel; Lowell E Schnipper
Journal:  J Clin Oncol       Date:  2009-07-06       Impact factor: 44.544

9.  Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

Authors:  Wanling Xie; Meredith M Regan; Marc Buyse; Susan Halabi; Philip W Kantoff; Oliver Sartor; Howard Soule; Noel W Clarke; Laurence Collette; James J Dignam; Karim Fizazi; Wendy R Paruleker; Howard M Sandler; Matthew R Sydes; Bertrand Tombal; Scott G Williams; Christopher J Sweeney
Journal:  J Clin Oncol       Date:  2017-08-10       Impact factor: 44.544

10.  Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.

Authors:  Edoardo Francini; Kathryn P Gray; Grace K Shaw; Carolyn P Evan; Anis A Hamid; Caitlin E Perry; Philip W Kantoff; Mary-Ellen Taplin; Christopher J Sweeney
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-01-14       Impact factor: 5.554
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.